{"id":1004980,"date":"2026-09-22T07:33:46","date_gmt":"2026-09-22T11:33:46","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/cervomed-to-participate-in-the-5th-annual-roth-healthcare-opportunities-conference\/"},"modified":"2026-09-22T07:33:46","modified_gmt":"2026-09-22T11:33:46","slug":"cervomed-to-participate-in-the-5th-annual-roth-healthcare-opportunities-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/cervomed-to-participate-in-the-5th-annual-roth-healthcare-opportunities-conference\/","title":{"rendered":"CervoMed to Participate in the 5th Annual ROTH Healthcare Opportunities Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p>BOSTON, Sept.  22, 2026  (GLOBE NEWSWIRE) &#8212; CervoMed Inc. (NASDAQ: CRVO), a clinical stage company focused on developing treatments for age-related neurologic disorders (CervoMed or the Company), today announced that Company management will participate in a panel discussion and one-on-one meetings at the upcoming 5th Annual ROTH Healthcare Opportunities Conference being held in New York, NY, on Tuesday, September 29, 2026.<\/p>\n<p>\n        <strong>Panel Details<\/strong><br \/>\n        <br \/>Title: &#8220;Frontiers in Neuroscience&#8221;<br \/>Date: Tuesday, September 29, 2026<br \/>Time: 10:00 AM \u2013 10:50 AM ET<\/p>\n<p>This panel will not be webcast. A recording of the panel will be available following the conference. To request a meeting or for more details about the Conference, please reach out to your institutional representative at Roth or contact <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=cdG_cvYyunaxNmpyrwZXta94qQgyAjc3BXESxaJMSD9zqcN_NAUZG-N9X1EfSWhM_qcuE09e-6fE3cAFOFKagl3DcITV7iRlwDyRLwMGNzhUyOwQXDdv4oAGlv9J0HJ5\" rel=\"nofollow\" target=\"_blank\">cervomed@argotpartners.com<\/a>.\u00a0<\/p>\n<p>\n        <strong>About CervoMed<\/strong>\n      <\/p>\n<p>CervoMed is a clinical-stage company developing treatments for age-related brain disorders. Its lead drug candidate, neflamapimod, is an oral small molecule targeting critical disease processes underlying degenerative disorders of the brain by inhibiting a key enzyme involved in neuroinflammation and neurodegeneration. CervoMed\u2019s recently completed Phase 2b RewinD-LB trial evaluated neflamapimod in patients with DLB, enriched for those without AD co-pathology, and the Company announced alignment with the FDA on a potential registration path for neflamapimod in DLB in November 2025. Initiation of a Phase 3 trial in DLB is subject to the establishment of a partnership and\/or additional financing. CervoMed also recently completed enrollment in its ongoing Phase 2a clinical trial evaluating neflamapimod in nfvPPA, a subtype of frontotemporal disorders, from which interim biomarker data is anticipated in the early fourth quarter of 2026, and expects the first patient to be dosed with neflamapimod in the EXPERTS-ALS Phase 2a clinical trial in the fourth quarter of 2026.<\/p>\n<p>\n        <strong>Contacts:<\/strong>\n      <\/p>\n<p>\n        <strong>Media:<\/strong><br \/>\n        <br \/>Lisa Guiterman<br \/>Biongage Communications<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=YFtuGtwMyZSb4Tx5QuMuJQ7Fbwk9t5YAfoXZ2pQ5y1e4oQEVBTzfN-h17xPNqm7i4nnH83WyipAjGE1ryvZhVFxAlSPBdis5OkH5vUhqY17IwBbtBMOdQnOYZvKs86xQcHFPuyZ-V5nnddQHdDWappfEal3__946c8ym6xS4oykUZ31ZdfaDqjOy_Yp2cWO2hh8YrtY7TspZjijc40-2tWil3kKfHgX5DE3fCRLLxkUcNRG4pWjQyO9zJDg76IbQTX9w3e0qbK26SEoSP8mTEluHyOzEuOoWPKeLfFVZvb0=\" rel=\"nofollow\" target=\"_blank\">lisa.guiterman@gmail.com<\/a><br \/>202-330-3431<\/p>\n<p>\n        <strong>Investor Relations:<\/strong><br \/>\n        <br \/>Argot Partners<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=cdG_cvYyunaxNmpyrwZXta94qQgyAjc3BXESxaJMSD97nfP9cGUB8ju_sS0r-3msD2XhXtPTE9qS0fnb7vr8-AnBeEJeQwys11BmHS2YN42FdJUT2zSsMDrfMWcsVa0vgNkjS-DBaDChmsQgKkQuaCGTcyuMV1_Kvc6pQjOoKGf45b-f_r8wT-A_feE0r1lvrQxsVDF_H1B0eSJfEnWVvEA-a1AgSp-HJWvBMjPwnVCXVahXe5MQHH9wUiZRF-Eb1zf6X88ip4Xqzv3gC5yAAYP7OoqldWZdIBt9S-wUTdg=\" rel=\"nofollow\" target=\"_blank\">cervomed@argotpartners.com<\/a><br \/>212-600-1902\u00a0<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgzMTEwMyM3ODU1MjM3IzIxODQ1ODU=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/ZjhjNDZjMmYtZTcyYi00NjYwLWFjMDItMTI3Y2UyOGI2YWExLTExOTYxMzktMjAyNi0wOS0yMi1lbg==\/tiny\/Cervomed.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>BOSTON, Sept. 22, 2026 (GLOBE NEWSWIRE) &#8212; CervoMed Inc. (NASDAQ: CRVO), a clinical stage company focused on developing treatments for age-related neurologic disorders (CervoMed or the Company), today announced that Company management will participate in a panel discussion and one-on-one meetings at the upcoming 5th Annual ROTH Healthcare Opportunities Conference being held in New York, NY, on Tuesday, September 29, 2026. Panel Details Title: &#8220;Frontiers in Neuroscience&#8221;Date: Tuesday, September 29, 2026Time: 10:00 AM \u2013 10:50 AM ET This panel will not be webcast. A recording of the panel will be available following the conference. To request a meeting or for more details about the Conference, please reach out to your institutional representative at Roth or contact cervomed@argotpartners.com.\u00a0 About CervoMed CervoMed &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/cervomed-to-participate-in-the-5th-annual-roth-healthcare-opportunities-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;CervoMed to Participate in the 5th Annual ROTH Healthcare Opportunities Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-1004980","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>CervoMed to Participate in the 5th Annual ROTH Healthcare Opportunities Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/cervomed-to-participate-in-the-5th-annual-roth-healthcare-opportunities-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CervoMed to Participate in the 5th Annual ROTH Healthcare Opportunities Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"BOSTON, Sept. 22, 2026 (GLOBE NEWSWIRE) &#8212; CervoMed Inc. (NASDAQ: CRVO), a clinical stage company focused on developing treatments for age-related neurologic disorders (CervoMed or the Company), today announced that Company management will participate in a panel discussion and one-on-one meetings at the upcoming 5th Annual ROTH Healthcare Opportunities Conference being held in New York, NY, on Tuesday, September 29, 2026. Panel Details Title: &#8220;Frontiers in Neuroscience&#8221;Date: Tuesday, September 29, 2026Time: 10:00 AM \u2013 10:50 AM ET This panel will not be webcast. A recording of the panel will be available following the conference. To request a meeting or for more details about the Conference, please reach out to your institutional representative at Roth or contact cervomed@argotpartners.com.\u00a0 About CervoMed CervoMed &hellip; Continue reading &quot;CervoMed to Participate in the 5th Annual ROTH Healthcare Opportunities Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/cervomed-to-participate-in-the-5th-annual-roth-healthcare-opportunities-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-09-22T11:33:46+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgzMTEwMyM3ODU1MjM3IzIxODQ1ODU=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cervomed-to-participate-in-the-5th-annual-roth-healthcare-opportunities-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cervomed-to-participate-in-the-5th-annual-roth-healthcare-opportunities-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"CervoMed to Participate in the 5th Annual ROTH Healthcare Opportunities Conference\",\"datePublished\":\"2026-09-22T11:33:46+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cervomed-to-participate-in-the-5th-annual-roth-healthcare-opportunities-conference\\\/\"},\"wordCount\":300,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cervomed-to-participate-in-the-5th-annual-roth-healthcare-opportunities-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgzMTEwMyM3ODU1MjM3IzIxODQ1ODU=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cervomed-to-participate-in-the-5th-annual-roth-healthcare-opportunities-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cervomed-to-participate-in-the-5th-annual-roth-healthcare-opportunities-conference\\\/\",\"name\":\"CervoMed to Participate in the 5th Annual ROTH Healthcare Opportunities Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cervomed-to-participate-in-the-5th-annual-roth-healthcare-opportunities-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cervomed-to-participate-in-the-5th-annual-roth-healthcare-opportunities-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgzMTEwMyM3ODU1MjM3IzIxODQ1ODU=\",\"datePublished\":\"2026-09-22T11:33:46+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cervomed-to-participate-in-the-5th-annual-roth-healthcare-opportunities-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cervomed-to-participate-in-the-5th-annual-roth-healthcare-opportunities-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cervomed-to-participate-in-the-5th-annual-roth-healthcare-opportunities-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgzMTEwMyM3ODU1MjM3IzIxODQ1ODU=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgzMTEwMyM3ODU1MjM3IzIxODQ1ODU=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cervomed-to-participate-in-the-5th-annual-roth-healthcare-opportunities-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CervoMed to Participate in the 5th Annual ROTH Healthcare Opportunities Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CervoMed to Participate in the 5th Annual ROTH Healthcare Opportunities Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/cervomed-to-participate-in-the-5th-annual-roth-healthcare-opportunities-conference\/","og_locale":"en_US","og_type":"article","og_title":"CervoMed to Participate in the 5th Annual ROTH Healthcare Opportunities Conference - Market Newsdesk","og_description":"BOSTON, Sept. 22, 2026 (GLOBE NEWSWIRE) &#8212; CervoMed Inc. (NASDAQ: CRVO), a clinical stage company focused on developing treatments for age-related neurologic disorders (CervoMed or the Company), today announced that Company management will participate in a panel discussion and one-on-one meetings at the upcoming 5th Annual ROTH Healthcare Opportunities Conference being held in New York, NY, on Tuesday, September 29, 2026. Panel Details Title: &#8220;Frontiers in Neuroscience&#8221;Date: Tuesday, September 29, 2026Time: 10:00 AM \u2013 10:50 AM ET This panel will not be webcast. A recording of the panel will be available following the conference. To request a meeting or for more details about the Conference, please reach out to your institutional representative at Roth or contact cervomed@argotpartners.com.\u00a0 About CervoMed CervoMed &hellip; Continue reading \"CervoMed to Participate in the 5th Annual ROTH Healthcare Opportunities Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/cervomed-to-participate-in-the-5th-annual-roth-healthcare-opportunities-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2026-09-22T11:33:46+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgzMTEwMyM3ODU1MjM3IzIxODQ1ODU=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cervomed-to-participate-in-the-5th-annual-roth-healthcare-opportunities-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cervomed-to-participate-in-the-5th-annual-roth-healthcare-opportunities-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"CervoMed to Participate in the 5th Annual ROTH Healthcare Opportunities Conference","datePublished":"2026-09-22T11:33:46+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cervomed-to-participate-in-the-5th-annual-roth-healthcare-opportunities-conference\/"},"wordCount":300,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cervomed-to-participate-in-the-5th-annual-roth-healthcare-opportunities-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgzMTEwMyM3ODU1MjM3IzIxODQ1ODU=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cervomed-to-participate-in-the-5th-annual-roth-healthcare-opportunities-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/cervomed-to-participate-in-the-5th-annual-roth-healthcare-opportunities-conference\/","name":"CervoMed to Participate in the 5th Annual ROTH Healthcare Opportunities Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cervomed-to-participate-in-the-5th-annual-roth-healthcare-opportunities-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cervomed-to-participate-in-the-5th-annual-roth-healthcare-opportunities-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgzMTEwMyM3ODU1MjM3IzIxODQ1ODU=","datePublished":"2026-09-22T11:33:46+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cervomed-to-participate-in-the-5th-annual-roth-healthcare-opportunities-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/cervomed-to-participate-in-the-5th-annual-roth-healthcare-opportunities-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cervomed-to-participate-in-the-5th-annual-roth-healthcare-opportunities-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgzMTEwMyM3ODU1MjM3IzIxODQ1ODU=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgzMTEwMyM3ODU1MjM3IzIxODQ1ODU="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cervomed-to-participate-in-the-5th-annual-roth-healthcare-opportunities-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"CervoMed to Participate in the 5th Annual ROTH Healthcare Opportunities Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1004980","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=1004980"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1004980\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=1004980"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=1004980"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=1004980"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}